Kidney Disease Clinical Trials

Showing 3201-3220 of 3,902 trials

Rapid Renal Sympathetic Denervation for Resistant Hypertension II

NCT01939392

This is a global, multi-center, prospective, randomized, controlled study of the safety and effectiveness of renal denervation with the OneShot Renal Denervation System in patients with uncontrolled hypertension.

Resistant HypertensionUncontrolled HypertensionRenal Artery Ablation

Medtronic EndovascularStarted Sep 2013

Milan, Italy

COMPLETEDNA

Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.

NCT02112071

The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).

Focus Type 2 Diabetes Related Chronic Kidney Disease

University of Minnesota122 participantsStarted Oct 2009

Minneapolis, Minnesota, United States

COMPLETEDPhase 2

Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

NCT00496483

A three sequence, open-label, multi-center, prospective, study in stable kidney transplant patients to assess and compare the pharmacokinetics (Cmax, C24, and AUC), and safety of LCP-Tacro (tacrolimus) tablets versus Prograf (tacrolimus) capsules.

Renal Failure

Veloxis Pharmaceuticals60 participantsStarted Jul 2007

Cincinnati, Ohio, United States • Houston, Texas, United States

Rapid Renal Sympathetic Denervation for Resistant Hypertension II

Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.

Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

Related Searches

Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone

A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death

Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation

Improvement of Humoral Immune Response With Hemodialysis on BK-F Membrane: Correlation to Soluble CD40 Clearing

Effects of High vs. Standard Protein Intake in Newborn Extreme Premature

Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)

Metabolomic Profiling in Renal Cell Carcinoma

Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer

Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma

Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Renal Safety Evaluation After Dotarem®-Enhanced MRI

Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease

Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients